Clinicopathological variables | TCGA cohort | TFAHCQMU cohort | ||||
---|---|---|---|---|---|---|
 | Low risk | High risk | P-value | Low risk | High risk | P-value |
Age | Â | Â | 0.655 | Â | Â | 0.108 |
< 60 | 72 | 76 |  | 19 | 13 |  |
≥60 | 89 | 85 |  | 6 | 11 |  |
Gender | Â | Â | 0.012* | Â | Â | 0.675 |
Male | 121 | 100 | Â | 20 | 18 | Â |
Female | 40 | 61 | Â | 5 | 6 | Â |
Cirrhosis | Â | Â | 0.862 | Â | Â | 0.308 |
Negative | 64 | 51 | Â | 13 | 9 | Â |
Positive | 41 | 31 | Â | 12 | 15 | Â |
AJCC stage | Â | Â | 0.016* | Â | Â | 0.049* |
I-II | 124 | 106 | Â | 24 | 18 | Â |
III-IV | 28 | 46 | Â | 1 | 6 | Â |
Tumor grade | Â | Â | 0.758 | Â | Â | 0.928 |
I-II | 103 | 101 | Â | 18 | 17 | Â |
III-IV | 56 | 59 | Â | 7 | 7 | Â |
Vascular invasion | Â | Â | 0.028* | Â | Â | 0.004** |
Negative | 105 | 81 | Â | 22 | 12 | Â |
Positive | 40 | 54 | Â | 3 | 12 | Â |